Depot risperidone-induced adverse metabolic alterations in female rats
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62157124%3A16370%2F17%3A43875715" target="_blank" >RIV/62157124:16370/17:43875715 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/17:00096183
Result on the web
<a href="http://dx.doi.org/10.1177/0269881117691466" target="_blank" >http://dx.doi.org/10.1177/0269881117691466</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1177/0269881117691466" target="_blank" >10.1177/0269881117691466</a>
Alternative languages
Result language
angličtina
Original language name
Depot risperidone-induced adverse metabolic alterations in female rats
Original language description
Atypical antipsychotics are associated with adverse metabolic effects including weight gain, increased adiposity, dyslipidaemia, alterations in glucose metabolism and insulin resistance. Increasing evidence suggests that metabolic dysregulation precedes weight gain development. The aim of this study was to evaluate alterations in adipokines, hormones and basic serum biochemical parameters induced by chronic treatment with depot risperidone at two doses (20 and 40 mg/kg) in female Sprague-Dawley rats. Dose-dependent metabolic alterations induced by risperidone after 6 weeks of treatment were revealed. Concomitant to weight gain and increased liver weight, an adverse lipid profile with an elevated triglyceride level was observed in the high exposure group, administered a 40 mg/kg dose repeatedly, while the low dose exposure group, administered a 20 mg/kg dose, developed weight gain without alterations in the lipid profile and adipokine levels. An initial peak in leptin serum level after the higher dose was observed in the absence of weight gain. This finding may indicate that the metabolic alterations observed in this study are not consequent to body weight gain. Taken together, these data may support the primary effects of atypical antipsychotics on peripheral tissues.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of psychopharmacology
ISSN
0269-8811
e-ISSN
—
Volume of the periodical
31
Issue of the periodical within the volume
4
Country of publishing house
GB - UNITED KINGDOM
Number of pages
13
Pages from-to
487-499
UT code for WoS article
000400179400009
EID of the result in the Scopus database
—